PolyPid (PYPD) Tax Rate (2022 - 2025)

PolyPid (PYPD) posted Tax Rate of 0.95% for Q4 2025, down 419.76% sequentially from 0.3% in Q3 2025, and down 110.0% YoY from 9.47% in Q4 2024.

PolyPid (PYPD) Tax Rate (2022 - 2025) Analysis & Trends

PolyPid has reported Tax Rate for 4 years, with the latest figure at 0.95% in Q4 2025.

Quarterly Tax Rate fell 110.0% year-over-year to 0.95% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (down 13.0% YoY) and the FY2025 annual result came in at 0.01%, up 13.0% from the prior year.
Tax Rate retreated to 0.95% in Q4 2025 per PYPD's latest filing, from 0.3% in the prior quarter.
Over five years, Tax Rate peaked at 0.84% in Q4 2022 and troughed at 0.95% in Q4 2025.
A 4-year average of 0.24% and a median of 0.22% in 2023 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 50 bps in 2025, down 110 bps in 2025.
Over 4 years, Tax Rate stood at 0.84% in 2022, then tumbled by 83 bps to 0.14% in 2023, then gained by 8 bps to 0.15% in 2024, then tumbled by 720 bps to 0.95% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 0.95%, 0.3%, and 0.53% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	15.11%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	10.91%
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	7.49%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-16.71%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	34.12%
10	PolyPid	113.30 Mn	106.53 Mn	-	-

Download Data